MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/adhm.202400378

Медицинская библиотека · Advanced healthcare materials · 2024

Pyridine-2,6-Dicarboxamide Proligands and their Cu(II)/Zn(II) Complexes Targeting Staphylococcus Aureus for the Attenuation of In Vivo Dental Biofilm.

Chaudhary Kajal, Agrahari Bhumika, Biswas Bhumika, Chatterjee Niranjan, Chaudhary Ayushi, Kumar Ashwini, Sonker Himanshu, Dewan Sayari, Saxena Deepanshi, Akhir Abdul, Malhotra Nidhi, Chopra Sidharth, Misra Santosh, Matheswaran Saravanan, Singh Ritika Gautam

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

In the pursuit to combat stubborn bacterial infections, particularly those stemming from gram-positive bacteria, this study is an attempt to craft a precision-driven platform characterized by unparalleled selectivity, specificity, and synergistic antimicrobial mechanisms. Leveraging remarkable potential of metalloantibiotics in antimicrobial applications, herein, this work rationally designs, synthesizes, and characterizes a new library of Pyridine-2,6-dicarboxamide ligands and their corresponding transition metal Cu(II)/Zn(II) complexes. The lead compound L11 demonstrates robust antibacterial properties against Staphylococcus aureus (Minimum Inhibitory Concentration (MIC) = 2-16 µg mL-1), methicillin and vancomycin-resistant S. aureus (MIC = 2-4 µg mL-1) and exhibit superior antibacterial activity when compared to FDA-approved vancomycin, the drug of last resort. Additionally, the compound exhibits notable antimicrobial efficacy against resistant enterococcus strains (MIC = 2-8 µg mL-1). To unravel mechanistic profile, advanced imaging techniques including SEM and AFM are harnessed, collectively suggesting a mechanistic pathway involving cell wall disruption. Live/dead fluorescence studies further confirm efficacy of L11 and its complexes against S. aureus membranes. This translational exploration extends to a rat model, indicating promising in vivo therapeutic potential. Thus, this comprehensive research initiative has capabilities to transcends the confines of this laboratory, heralding a pivotal step toward combatting antibiotic-resistant pathogens and advancing the frontiers of metalloantibiotics-based therapy with a profound clinical implication.

Для цитирования: Chaudhary Kajal, Agrahari Bhumika, Biswas Bhumika, Chatterjee Niranjan, Chaudhary Ayushi, Kumar Ashwini, Sonker Himanshu, Dewan Sayari, Saxena Deepanshi, Akhir Abdul, Malhotra Nidhi, Chopra Sidharth, Misra Santosh, Matheswaran Saravanan, Singh Ritika Gautam. Pyridine-2,6-Dicarboxamide Proligands and their Cu(II)/Zn(II) Complexes Targeting Staphylococcus Aureus for the Attenuation of In Vivo Dental Biofilm.. Advanced healthcare materials. 2024. DOI: 10.1002/adhm.202400378.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.